Tamoxifen [clinicaltrials_resource:cc465cbd8e026ce19e040ef7958aba78]
condition [clinicaltrials_vocabulary:condition]
Tamoxifen Study [clinicaltrials:NCT00000529]A Phase I Study of OncoLARĀ® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma [clinicaltrials:NCT00001436]Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer [clinicaltrials:NCT00002460]clinicaltrials:NCT00002528clinicaltrials:NCT00002529Tamoxifen in Treating Women With High-Risk Breast Cancer [clinicaltrials:NCT00002542]Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer [clinicaltrials:NCT00002579]Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [clinicaltrials:NCT00002580]Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer [clinicaltrials:NCT00002581]Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [clinicaltrials:NCT00002582]Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [clinicaltrials:NCT00002608]Tamoxifen for the Prevention of Breast Cancer in High-Risk Women [clinicaltrials:NCT00002644]Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer [clinicaltrials:NCT00002646]Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer [clinicaltrials:NCT00002679]Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer [clinicaltrials:NCT00002680]clinicaltrials:NCT00002707Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer [clinicaltrials:NCT00002720]Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer [clinicaltrials:NCT00002755]clinicaltrials:NCT00002772Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer [clinicaltrials:NCT00002777]clinicaltrials:NCT00002784clinicaltrials:NCT00002864clinicaltrials:NCT00002920Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [clinicaltrials:NCT00002967]Chemotherapy Plus Surgery in Treating Women With Breast Cancer [clinicaltrials:NCT00003013]Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer [clinicaltrials:NCT00003016]High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer [clinicaltrials:NCT00003032]Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer [clinicaltrials:NCT00003035]clinicaltrials:NCT00003042Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer [clinicaltrials:NCT00003050]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]clinicaltrials:NCT00003099Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer [clinicaltrials:NCT00003418]Tamoxifen in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00003424]Tamoxifen in Treating Women With Breast Cancer [clinicaltrials:NCT00003678]Combination Chemotherapy in Treating Women With Breast Cancer [clinicaltrials:NCT00003679]Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer [clinicaltrials:NCT00003680]clinicaltrials:NCT00003857clinicaltrials:NCT00003906
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Tamoxifen [clinicaltrials_resource:cc465cbd8e026ce19e040ef7958aba78]
Bio2RDF identifier
cc465cbd8e026ce19e040ef7958aba78
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cc465cbd8e026ce19e040ef7958aba78
identifier
clinicaltrials_resource:cc465cbd8e026ce19e040ef7958aba78
title
Tamoxifen
@en
type
label
Tamoxifen [clinicaltrials_resource:cc465cbd8e026ce19e040ef7958aba78]
@en